Trial Profile
Clinical Trials Insight: 700049191
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2009
Price :
$35
*
At a glance
- Drugs CP 481715 (Primary) ; Ciclosporin
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 25 Sep 2009 New trial record.